Sfoglia per AUTORE
DE FRANCIA S
Collezione AOU San Luigi di Orbassano

  

Items : 51

Central Serous Chorioretinopathy in Endometriosis Treatment with Progestogen: A Metabolic Understanding. in Life (Basel, Switzerland) / Life (Basel). 2025 Jan 22;15(2):144. doi: 10.3390/life15020144.
2025
ASL Città di Torino
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

De Francia S; Mengozzi G; Liuzzi S; Puccinelli MP; Turco D; Caudana M; Mula J; Allegra S; Chiara F;

2025
AOU San Luigi di Orbassano

Chiara F; Allegra S; Arrigo E; Di Grazia D; Shelton Agar FMA; Abalai RE; Gilardi S; De Francia S; Mancardi D;

Gender Medicine and Pharmacology. in Biomedicines / Biomedicines. 2024 Jan 24;12(2):265. doi: 10.3390/biomedicines12020265.
2024
AOU San Luigi di Orbassano

Allegra S; Chiara F; De Francia S;

Self-Completion Questionnaire on Sleep Evaluation in Patients Undergoing Oxaliplatin Therapy: An Observational Study. in Cancers / Cancers (Basel). 2024 Feb 26;16(5):946. doi: 10.3390/cancers16050946.
2024
AOU San Luigi di Orbassano

Mussa MV; Allegra S; Armando T; Storto S; Ghezzo B; Soave G; Abbadessa G; Chiara F; Di Maio M; Dagnoni FM; De Francia S;

Sex and Gender Differences in Iron Chelation. in Biomedicines / Biomedicines. 2024 Dec 18;12(12):2885. doi: 10.3390/biomedicines12122885.
2024
AOU San Luigi di Orbassano

Allegra S; Comità S; Roetto A; De Francia S;

Pharmacokinetics of Four Tyrosine Kinase Inhibitors in Adult and Paediatric Chronic Myeloid Leukaemia Patients. in Biomedicines / Biomedicines. 2023 Sep 7;11(9):2478. doi: 10.3390/biomedicines11092478.
2023
AOU San Luigi di Orbassano

Allegra S; Dondi E; Chiara F; De Francia S;

Development and validation of high-performance liquid chromatography method for determination of clarithromycin in pharmaceutical tablets. in Journal of separation science / J Sep Sci. 2023 Nov;46(21):e2300424. doi: 10.1002/jssc.202300424. Epub 2023 Aug 31.
2023
AOU San Luigi di Orbassano

Mahmoudi A; De Francia S; Paul P;

Evaluation of Sex Differences in Preclinical Pharmacology Research: How Far Is Left to Go? in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2023 May 24;16(6):786. doi: 10.3390/ph16060786.
2023
AOU San Luigi di Orbassano

Allegra S; Chiara F; Di Grazia D; Gaspari M; De Francia S;

Tyrosine kinase inhibitors: the role of pharmacokinetics and pharmacogenetics. in Expert opinion on drug metabolism & toxicology / Expert Opin Drug Metab Toxicol. 2023 Jul-Dec;19(11):733-739. doi: 10.1080/17425255.2023.2277758. Epu
2023
AOU San Luigi di Orbassano

Sarah A; Dondi E; De Francia S;

Phytotherapy and Drugs: Can Their Interactions Increase Side Effects in Cancer Patients? in Journal of xenobiotics / J Xenobiot. 2023 Feb 1;13(1):75-89. doi: 10.3390/jox13010007.
2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Storto S; Armando T; Chiara F; Bertaggia I; Turco F; De Francia S; Allegra S; Mussa MV;

2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

De Francia S; Puccinelli MP; Mengozzi G; Zanatta M; Chiara F; Allegra S;

NURR1-deficient mice have age- and sex-specific behavioral phenotypes. in Journal of neuroscience research / J Neurosci Res. 2022 Sep;100(9):1747-1754. doi: 10.1002/jnr.25067. Epub 2022 May 20.
2022
AOU San Luigi di Orbassano

Montarolo F; Martire S; Chiara F; Allegra S; De Francia S; Hoxha E; Tempia F; Capobianco MA; Bertolotto A;

Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 May 20;15(5):630. doi: 10.3390/ph15050630.
2022
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Calcagno A; Rosa FG; Chiara F; Di Perri G; Allegra S; De Francia S; De Nicolò A; Antonucci M; Manca A; Mula J; Palermiti A; Cusato J;

Colorectal cancer chemotherapy: can sex-specific disparities impact on drug toxicities? in European journal of clinical pharmacology / Eur J Clin Pharmacol. 2022 Jun;78(6):1029-1038. doi: 10.1007/s00228-022-03298-y. Epub 2022 Feb 22.
2022
AOU San Luigi di Orbassano

De Francia S; Berchialla P; Armando T; Storto S; Allegra S; Sciannameo V; Soave G; Sprio AE; Racca S; Caiaffa MR; Ciuffreda L; Mussa MV;

Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical Carcinoma. in Biomedicines / Biomedicines. 2022 Aug 3;10(8):1873. doi: 10.3390/biomedicines10081873.
2022
AOU San Luigi di Orbassano

Allegra S; Puglisi S; Borin C; Chiara F; Basile V; Calabrese A; Reimondo G; De Francia S;

The Influence of Sex, Gender, and Age on COVID-19 Data in the Piedmont Region (Northwest Italy): The Virus Prefers Men. in Life (Basel, Switzerland) / Life (Basel). 2022 Apr 26;12(5):643. doi: 10.3390/life12050643.
2022
AOU San Luigi di Orbassano

Durio A; Ghisetti V; Avanzini C; Burdino E; Milia MG; Gregori G; Allice TG; Mancardi D; Allegra S; Ferretti A; Chiara F; De Francia S;

Gender-specific side effects of chemotherapy in pancreatic cancer patients. in Canadian journal of physiology and pharmacology / Can J Physiol Pharmacol. 2022 Apr;100(4):371-377. doi: 10.1139/cjpp-2021-0622. Epub 2021 Oct 21.
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Mussa MV; Ciuffreda L; Carnovale J; Racca S; Chiara F; Soave G; Allegra S; Storto S; Armando T; Berchialla P; De Francia S; Mancardi D;

Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma. in Life (Basel, Switzerland) / Life (Basel). 2021 Mar 23;11(3):266. doi: 10.3390/life11030266.
2021
AOU San Luigi di Orbassano

Allegra S; Puglisi S; Brescia I; Chiara F; Basile V; Calabrese A; Reimondo G; De Francia S;

2020
AOU San Luigi di Orbassano

Mahmoudi A; Terti? M; Simon LM; Van Schepdael A; De Francia S; Junie LM; S?ndulescu R;

Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients. in European journal of drug metabolism and pharmacokinetics / Eur J Drug Metab Pharmacokinet. 2020 Jun;45(3):405-412. doi: 10.1007/s13318-019-00603-6.
2020
ASL Città di Torino
AOU San Luigi di Orbassano

Antonucci M; D'Avolio A; Manca A; Avataneo V; Cusato J; Allegra S; De Francia S; De Nicolò A;

2020
AOU San Luigi di Orbassano

Altieri B; Sbiera S; Herterich S; De Francia S; Della Casa S; Calabrese A; Pontecorvi A; Quinkler M; Kienitz T; Mannelli M; Canu L; Angelousi A; Chortis V; Kroiss M; Terzolo M; Fassnacht M; Ronchi CL;

The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients. in The pharmacogenomics journal / Pharmacogenomics J. 2019 Oct;19(5):417-427. doi: 10.1038/s41397-019-0071-7. Epub 2019 Jan 17.
2019
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Avataneo V; Massano D; Pirro E; Longo F; De Francia S; Cusato J; Allegra S; D'Avolio A;

NURR1 deficiency is associated to ADHD-like phenotypes in mice. in Translational psychiatry / Transl Psychiatry. 2019 Aug 27;9(1):207. doi: 10.1038/s41398-019-0544-0.
2019
AOU San Luigi di Orbassano

Montarolo F; Martire S; Perga S; Spadaro M; Brescia I; Allegra S; De Francia S; Bertolotto A;

Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2018 Sep;28(9):199-206. doi: 10.1097/FPC.0000000000000348.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Avataneo V; Pirro E; Massano D; De Francia S; Longo F; Cusato J; Allegra S; D'Avolio A;

Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes. in The pharmacogenomics journal / Pharmacogenomics J. 2018 May 22;18(3):506-515. doi: 10.1038/tpj.2017.43. Epub 2017 Nov 21.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Massano D; Pirro E; Longo F; Arduino A; De Francia S; Cusato J; Allegra S; D'Avolio A; Allegra S; Cusato J; De Francia S; Arduino A; Longo F; Pirro E; Massano D; De Nicolò A; Piga A; D'Avolio A;

Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Jan;84(1):197-203. doi: 10.1111/bcp.13401. Epub 2017 Sep 24.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; De Nicolò A; Cusato J; Pirro E; Carcieri C; De Francia S; Favata F; Fatiguso G; Allegra S; Allegra S; Fatiguso G; De Francia S; Favata F; Pirro E; Carcieri C; De Nicolò A; Cusato J; Di Perri G; D'Avolio A;

Clinical relevance of deferasirox trough levels in ?-thalassemia patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2018 Feb;45(2):213-216. doi: 10.1111/1440-1681.12879. Epub 2017 Dec 4.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Cusato J; Pirro E; Piccione F; Longo F; De Francia S; Massano D; Allegra S; Piga A; Allegra S; Massano D; De Francia S; Longo F; Piccione F; Pirro E; Cusato J; D'Avolio A; Piga A;

CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells. in PloS one / PLoS One. 2018 May 7;13(5):e0196931. doi: 10.1371/journal.pone.0196931. eCollection 2018.
2018
AOU San Luigi di Orbassano

Germano A; Saba L; De Francia S; Rapa I; Perotti P; Berruti A; Volante M; Terzolo M;

Subchronic nandrolone administration reduces cardiac oxidative markers during restraint stress by modulating protein expression patterns. in Molecular and cellular biochemistry / Mol Cell Biochem. 2017 Oct;434(1-2):51-60. doi: 10.1007/s11010-017-3036-7. Epub 2017 Apr 21.
2017
AOU San Luigi di Orbassano

Pergolizzi B; Carriero V; Abbadessa G; Penna C; Berchialla P; De Francia S; Bracco E; Racca S;

Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection. in Biomedicines / Biomedicines. 2017 Nov 20;5(4):66. doi: 10.3390/biomedicines5040066.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; Cusato J; Pirro E; Carcieri C; De Nicolò A; Favata F; De Francia S; Fatiguso G; Allegra S;

Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Nov;44(11):1083-1088. doi: 10.1111/1440-1681.12822. Epub 2017 Sep 5
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; De Nicolò A; Cusato J; Carcieri C; De Francia S; Favata F; Pirro E; Fatiguso G; Allegra S;

Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 Nov;69(11):1524-1530. doi: 10.1111/jphp.12798. Epub 2017 Aug 15.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

Tampellini M; Di Carlo F; Berruti A; Terzolo M; Daffara FC; Ferrero A; De Martino F; Piccione FM; Pirro E; Carrella S; Allegra S; De Francia S; Cusato J; D'Avolio A;

Deferasirox pharmacokinetic evaluation in ?-thalassaemia paediatric patients. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 May;69(5):525-528. doi: 10.1111/jphp.12559. Epub 2016 May 27.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Piga A; Massano D; Pirro E; De Francia S; Cusato J; Allegra S;

Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients. in Pharmacogenomics / Pharmacogenomics. 2017 Apr;18(6):539-554. doi: 10.2217/pgs-2016-0176. Epub 2017 Mar 27.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; Longo F; Massano D; Arduino A; Cusato J; De Francia S; Allegra S; D'Avolio A;

Deferasirox AUC efficacy cutoff and role of pharmacogenetics. in European journal of clinical pharmacology / Eur J Clin Pharmacol. 2016 Sep;72(9):1155-7. doi: 10.1007/s00228-016-2070-9. Epub 2016 May 18.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Massano D; Piga A; De Francia S; Cusato J; Allegra S;

Deferasirox pharmacokinetic and toxicity correlation in ?-thalassaemia major treatment. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2016 Nov;68(11):1417-1421. doi: 10.1111/jphp.12638. Epub 2016 Sep 27.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; Massano D; Pirro E; Cusato J; De Francia S; Allegra S; D'Avolio A;

Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous ?-thalassaemia. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2016 Dec;84:1510-1512. doi: 10.1016/j.biopha.2016.11.041. Epub 2016 Nov 20.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; Pirro E; Arduino A; Cusato J; Massano D; Longo F; De Francia S; Allegra S; D'Avolio A;

Role of pharmacogenetics on deferasirox AUC and efficacy. in Pharmacogenomics / Pharmacogenomics. 2016 Apr;17(6):561-72. doi: 10.2217/pgs-2015-0001. Epub 2016 Apr 4.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Piga A; Massano D; De Francia S; Allegra S; Cusato J;

RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization. in Molecular and cellular endocrinology / Mol Cell Endocrinol. 2015 Feb 5;401:105-10. doi: 10.1016/j.mce.2014.11.027. Epub 2014 Dec 9.
2015
AOU San Luigi di Orbassano

Germano A; Rapa I; Volante M; De Francia S; Migliore C; Berruti A; Papotti M; Terzolo M;

Plasma and intracellular imatinib concentrations in patients with chronic myeloid leukemia. in Therapeutic drug monitoring / Ther Drug Monit. 2014 Jun;36(3):410-2. doi: 10.1097/FTD.0000000000000013.
2014
AOU San Luigi di Orbassano

De Francia S; D?Avolio A; Ariaudo A; Pirro E; Piccione F; Simiele M; Fava C; Calcagno A; Di Perri G; Saglio G;

Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. in European journal of endocrinology / Eur J Endocrinol. 2013 Jul 29;169(3):263-70. doi: 10.1530/EJE-13-0242. Print 2013 Sep.
2013
AOU San Luigi di Orbassano

Terzolo M; Baudin AE; Ardito A; Kroiss M; Leboulleux S; Daffara F; Perotti P; Feelders RA; deVries JH; Zaggia B; De Francia S; Volante M; Haak HR; Allolio B; Al Ghuzlan A; Fassnacht M; Berruti A;

Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma. in European journal of endocrinology / Eur J Endocrinol. 2012 Mar;166(3):451-8. doi: 10.1530/EJE-11-0918. Epub 2011 Dec 21.
2012
AOU San Luigi di Orbassano

Berruti A; Sperone P; Ferrero A; Germano A; Ardito A; Priola AM; De Francia S; Volante M; Daffara F; Generali D; Leboulleux S; Perotti P; Baudin E; Papotti M; Terzolo M;

Management of adjuvant mitotane therapy following resection of adrenal cancer. in Endocrine / Endocrine. 2012 Dec;42(3):521-5. doi: 10.1007/s12020-012-9719-7. Epub 2012 Jun 17.
2012
AOU San Luigi di Orbassano

Terzolo M; Ardito A; Zaggia B; Laino F; Germano A; De Francia S; Daffara F; Berruti A;

Steroid resistance in nasal polyposis: role of glucocorticoid receptor and TGF-beta1. in Rhinology / Rhinology. 2012 Dec;50(4):427-35. doi: 10.4193/Rhino11.249.
2012
AOU San Luigi di Orbassano

Aversa S; Ondolo C; Abbadessa G; Piccione F; Carriero V; Fulcheri A; Lauria A; De Francia S; Racca S;

Effects of sub-chronic nandrolone administration on hormonal adaptive response to acute stress in rats. in Psychoneuroendocrinology / Psychoneuroendocrinology. 2012 Aug;37(8):1234-47. doi: 10.1016/j.psyneuen.2011.12.017. Epub 2012 Jan
2012
AOU San Luigi di Orbassano

Racca S; Piccione F; Spaccamiglio A; Carriero VM; De Francia S; Cangemi L; Esculapio P; Papotti M; Migliaretti G; Portaleone P; Di Carlo F; Abbadessa G;

A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Apr 15;893-894:127-33. doi: 10.1016/j.jchromb.20
2012
AOU San Luigi di Orbassano

De Francia S; Massano D; Piccione FM; Pirro E; Racca S; Di Carlo F; Piga A;

A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients. in Journal of chromatographic science / J Chromatogr Sci. 2011 Nov-Dec;49(10):753-7. doi: 10.1093/chrsci/49.10.753.
2011
AOU San Luigi di Orbassano

Pirro E; De Francia S; De Martino F; Fava C; Ulisciani S; Cambrin GR; Racca S; Saglio G; Di Carlo F;

New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jun 15;877(18-19):1721-6. doi: 10.1016/j.jchromb
2009
AOU San Luigi di Orbassano

De Francia S; D'Avolio A; De Martino F; Pirro E; Baietto L; Siccardi M; Simiele M; Racca S; Saglio G; Di Carlo F; Di Perri G;

The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome. in European journal of endocrinology / Eur J Endocrinol. 2008 Nov;159(5):569-76. doi: 10.1530/EJE-08-0402. Epub 2008 Aug 19.
2008
AOU San Luigi di Orbassano

Reimondo G; Bovio S; Allasino B; De Francia S; Zaggia B; Micossi I; Termine A; De Martino F; Paccotti P; Di Carlo F; Angeli A; Terzolo M;

Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly. in Endocrine-related cancer / Endocr Relat Cancer. 2008 Dec;15(4):1043-53. doi: 10.1677/ERC-08-0103. Epub 2008 Sep 29.
2008
AOU San Luigi di Orbassano

Daffara F; De Francia S; Reimondo G; Zaggia B; Aroasio E; Porpiglia F; Volante M; Termine A; Di Carlo F; Dogliotti L; Angeli A; Berruti A; Terzolo M;

A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jun 6;837(1-2):69-75. doi: 10.1016/j.jchromb.200
2006
AOU San Luigi di Orbassano

De Francia S; Pirro E; Zappia F; De Martino F; Sprio AE; Daffara F; Terzolo M; Berruti A; Di Carlo F; Ghezzo F;